Cannabis Flower Labels Consistently Overstated THC Content Compared to Independent Testing
Independent testing of 74 cannabis products from licensed Colorado dispensaries found that flower product labels significantly overstated THC content, with some falling outside the legally allowed 15% variance.
Quick Facts
What This Study Found
Overall, label values were significantly higher than tested values for flower and edible products (p<0.001), but not for concentrates (p=0.85). Flower products were significantly lower than labels even accounting for the 15% legal variance (p=0.04). Concentrates and edibles fell within legally allowable ranges.
Key Numbers
74 products tested from licensed Colorado dispensaries. Flower labels significantly overstated THC (p<0.001) and exceeded the 15% legal variance (p=0.04). Concentrate labels were accurate (p=0.85). Edible labels overstated THC (p<0.001) but within legal variance (p=0.5).
How They Did This
Observational study collecting cannabis samples from a larger impairment study. 74 flower, concentrate, and edible products purchased from licensed Colorado dispensaries were independently tested for THC concentration and compared to label claims.
Why This Research Matters
Consumers often choose cannabis products based on labeled THC percentages. If flower labels systematically overstate potency, consumers may be making purchasing decisions based on inaccurate information, and paying more for products marketed as "higher potency."
The Bigger Picture
THC potency inflation on labels has been suspected in the cannabis industry. This independent testing confirms the problem exists, particularly for flower products, and raises questions about testing lab practices and regulatory enforcement.
What This Study Doesn't Tell Us
Small sample size (74 products). Products came from one geographic area (Denver metro). Voluntary donation of samples may introduce selection bias. Testing methodology differences between labs could account for some variance.
Questions This Raises
- ?Are testing labs incentivized to report higher THC values?
- ?How widespread is label inflation across other legal cannabis markets?
- ?Should regulators require more stringent testing standards?
Trust & Context
- Key Stat:
- Flower THC labels were significantly inflated beyond the 15% legally allowed variance
- Evidence Grade:
- Preliminary: small observational study from one region with voluntary sample donation, though findings align with broader industry concerns.
- Study Age:
- 2025 preprint (medRxiv).
- Original Title:
- Commercial Cannabis Product Testing: Fidelity to Labels and Regulations.
- Published In:
- medRxiv : the preprint server for health sciences (2025)
- Authors:
- Limbacher, Sarah(3), Godbole, Suneeta(2), Wrobel, Julia(9), Mackie, Duncan I, Goldman, Stephen, Brooks-Russell, Ashley
- Database ID:
- RTHC-06952
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Were all cannabis product types equally inaccurate?
No. Flower products had the worst label accuracy, significantly overstating THC beyond legal limits. Concentrates were the most accurate. Edibles overstated but stayed within legal variance.
Why would labels overstate THC?
Higher THC percentages may drive sales and higher prices. There are concerns about testing lab practices and insufficient regulatory oversight of accuracy standards.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-purity-potency-label-meaning
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dab-concentrate-addiction-withdrawal
- dating-sober-after-quitting-weed
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- healthiest-way-to-consume-cannabis
- help-someone-quit-weed
- how-cannabis-products-made-concentrates-edibles
- how-to-quit-weed
- journaling-weed-withdrawal
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- sativa-vs-indica-difference-myth
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-potency-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-06952APA
Limbacher, Sarah; Godbole, Suneeta; Wrobel, Julia; Mackie, Duncan I; Goldman, Stephen; Brooks-Russell, Ashley. (2025). Commercial Cannabis Product Testing: Fidelity to Labels and Regulations.. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2025.03.14.25323943
MLA
Limbacher, Sarah, et al. "Commercial Cannabis Product Testing: Fidelity to Labels and Regulations.." medRxiv : the preprint server for health sciences, 2025. https://doi.org/10.1101/2025.03.14.25323943
RethinkTHC
RethinkTHC Research Database. "Commercial Cannabis Product Testing: Fidelity to Labels and ..." RTHC-06952. Retrieved from https://rethinkthc.com/research/limbacher-2025-commercial-cannabis-product-testing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.